• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Union Square Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industriesIsembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries
    Isembard
    9 Mar 2026

    Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries

    Isembard manufactures high-precision components for aerospace, defence, energy and robotics companies. It operates its own and franchisee factories using proprietary software that integrates quoting, scheduling, supply chain, manufacturing, quality control and delivery.

    Volteras lands £8m Series A led by Union Square Ventures to expand EV and energy data platformVolteras lands £8m Series A led by Union Square Ventures to expand EV and energy data platform
    Volteras
    29 May 2025

    Volteras lands £8m Series A led by Union Square Ventures to expand EV and energy data platform

    Volteras runs a data streaming platform connecting electric vehicles, chargers and energy devices, enabling energy and mobility companies to access real-time, OEM-authorised data for fleet optimisation, maintenance, insurance and smarter energy management.

Union Square Ventures
    • Industrial
    • Energy
  • 2(12 months)
  • usv.com
  • Update Information

More venture news

  • Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
    Shellworks
    4 Mar 2026

    Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation

    Series ASupply Chain
  • Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries
    Isembard
    9 Mar 2026

    Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries

    Series AIndustrial
  • Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases
    Antiverse
    3 Mar 2026

    Antiverse secures £7m Series A led by Soulmates Ventures for AI-designed antibodies targeting undruggable diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn